Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | TERN-701 |
| Trade Name | |
| Synonyms | HS-10382|HS 10382|HS10382|TERN701|TERN 701 |
| Drug Descriptions |
TERN-701 is a selective BCR-ABL1 inhibitor with activity against the T315I mutation, which potentially inhibits tumor cell proliferation (Blood (2023) 142 (Supplement 1): 5757). |
| DrugClasses | BCR-ABL Inhibitor 32 |
| CAS Registry Number | NA |
| NCIT ID | C187661 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Dasatinib + TERN-701 | Dasatinib TERN-701 | 0 | 0 |
| Ponatinib + TERN-701 | Ponatinib TERN-701 | 0 | 0 |
| TERN-701 | TERN-701 | 0 | 1 |